MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED Panel
MRP - ₹ 14,000
What is a MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED Panel?
The Myeloproliferative Neoplasia (MPN) Extended Panel is a specialized genetic test that detects mutations associated with myeloproliferative disorders, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. This test is performed to confirm diagnosis, identify specific genetic abnormalities, and guide treatment decisions. It helps clinicians assess disease progression, tailor therapies, and provide valuable information for prognosis and family counseling, making it an essential tool in managing patients with suspected or confirmed MPN.
Additional Information
| Also known as/ Other names: | MPN Comprehensive Mutation Panel, MPN Extended NGS Panel, Myeloproliferative Disorder Extended Panel, MPN Extended Gene Mutation Analysis, Extended MPN Panel |
| Parameters: | 5 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood |
| Patient Preparation: | No prior preparation is needed |
| Reports: | 15 Days |
FAQs
Doctors recommend it to identify specific genetic mutations, confirm suspected MPNs, and provide clarity for prognosis, treatment planning, and family counseling.
Patients with unexplained high blood counts, enlarged spleen, or suspected polycythemia vera, essential thrombocythemia, or myelofibrosis should consider this test.
It detects mutations linked to polycythemia vera, essential thrombocythemia, primary myelofibrosis, and other related myeloproliferative neoplasms.
Yes, it provides definitive confirmation by identifying genetic mutations responsible for myeloproliferative neoplasms.
Yes, counseling helps patients and families understand results, inheritance patterns, and implications for future health decisions.
It identifies mutations but cannot precisely predict severity or progression, which varies among individuals.
Yes, children with symptoms or family history can be tested, though genetic counseling is advised before testing minors.
